The medicines industry is in a period of change. While small molecule therapeutics still make up 90% of approved medicines, patient expectations are driving the industry towards targeted, precision treatments, which require a shift towards stratified, complex medicines with more challenging discovery and development needs.
MDC Connects 2021: A Guide to Complex Medicines is a series of webinars exploring the opportunities and challenges presented by this new class of medicines, and takes you through the steps to take an idea from concept to the clinic.
In this first webinar, we will introduce the new and diverse field of complex medicines, the commercial opportunity presented and the current state of research in the UK community.
What is the commercial opportunity? – David Cook (Blueberry Therapeutics)
Shaping the UK into an international leader for complex medicines – Prof. Peter Simpson (MDC)
Complex medicines: The target landscape – Dr Duygu Yilmaz (MDC)
What is the commercial opportunity?
Shaping the UK into an international leader for complex medicines
Complex medicines: The target landscape